Laboratory of Seminology - "Loredana Gandini" Sperm Bank, Department of Experimental Medicine, "Sapienza" University of Rome, 00161, Rome, Italy.
Faculty of Medicine and Surgery, University of Enna "Kore", 94100, Enna, Italy.
J Endocrinol Invest. 2024 Mar;47(3):557-570. doi: 10.1007/s40618-023-02167-4. Epub 2023 Aug 16.
Human Papillomavirus (HPV) in semen represents a controversial topic. Recent evidence suggests a correlation with poor semen quality, but its detection is still unstandardized in this biological fluid. Thus, the aims of this study were to verify the ability of nested PCR to reveal HPV-DNA in semen; to evaluate association of seminal HPV with sperm parameters and risk factors for infection; to investigate the rate of HPV-DNA positivity in patients with and without risk factors; to assess HPV transcriptional activity.
We enrolled sexually active men and collected clinical and anamnestic data during andrological and sexually transmitted infections (STIs) evaluation. For each patient, we performed semen analysis and nested PCR to detect HPV-DNA in semen. In positive semen samples, we proceeded with genotyping and RNA quantification to detect HPV transcriptional activity.
We enrolled 185 men (36.0 ± 8.3 years), of which 85 with (Group A) and 100 without HPV risk factors (Group B). Nested PCR was able to reveal HPV-DNA in semen, discovering a prevalence of 8.6% (11.8% in Group A and 6% in Group B, respectively). We observed no correlation between sperm quality and seminal HPV. Genital warts and previous anogenital infection were significantly associated with the risk of HPV positivity in semen. Moreover, no viral transcriptional activity was detected in positive semen samples.
Our study suggests that searching for seminal HPV could be important in patients both with and without risk factors, especially in assisted reproduction where the risk of injecting sperm carrying HPV-DNA is possible.
精液中的人乳头瘤病毒(HPV)是一个备受争议的话题。最近的证据表明,HPV 与精液质量差有关,但在这种生物液中,其检测仍未标准化。因此,本研究的目的是验证巢式 PCR 检测精液中 HPV-DNA 的能力;评估精液 HPV 与精子参数和感染危险因素的相关性;调查有和无危险因素的患者中 HPV-DNA 阳性率;评估 HPV 转录活性。
我们招募了有性行为的男性,并在男科和性传播感染(STI)评估期间收集临床和病史数据。对每位患者,我们进行精液分析和巢式 PCR 检测以检测精液中的 HPV-DNA。在阳性精液样本中,我们进行基因分型和 RNA 定量以检测 HPV 转录活性。
我们共招募了 185 名男性(36.0±8.3 岁),其中 85 名有(A 组)和 100 名无 HPV 危险因素(B 组)。巢式 PCR 能够检测到精液中的 HPV-DNA,发现 HPV 阳性率为 8.6%(A 组为 11.8%,B 组为 6%)。我们观察到精子质量与精液 HPV 之间无相关性。生殖器疣和既往肛门生殖器感染与精液 HPV 阳性风险显著相关。此外,在阳性精液样本中未检测到病毒转录活性。
我们的研究表明,在有和无危险因素的患者中,寻找精液中的 HPV 可能很重要,尤其是在辅助生殖中,注射携带 HPV-DNA 的精子可能存在风险。